Home/Filings/4/A/0001493152-21-016685
4/A//SEC Filing

Yeh Yung-Ping 4/A

Accession 0001493152-21-016685

CIK 0001349929other

Filed

Jul 12, 8:00 PM ET

Accepted

Jul 13, 9:00 AM ET

Size

7.4 KB

Accession

0001493152-21-016685

Insider Transaction Report

Form 4/AAmended
Period: 2021-03-30
Yeh Yung-Ping
DirectorChief Innovation Officer
Transactions
  • Other

    Common Stock, $0.0001 par value

    2021-03-30+11,26211,262 total
  • Other

    Common Stock, $0.0001 par value

    2021-03-30+1,315,3631,315,363 total(indirect: By Trust)
Footnotes (1)
  • [F1]This amended Form 4 is being filed to correct (i) the number of shares of common stock $0.0001 par value (the "Common Stock") issued pursuant to the merger on March 30, 2021 and (ii) the disclosure of shares previously reported as owned directly that were transferred to a trust prior to the merger.

Documents

1 file

Issuer

Vyant Bio, Inc.

CIK 0001349929

Entity typeother

Related Parties

1
  • filerCIK 0001850320

Filing Metadata

Form type
4/A
Filed
Jul 12, 8:00 PM ET
Accepted
Jul 13, 9:00 AM ET
Size
7.4 KB